p|datav0.1news252
event5 outcomes

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Kalshi·Science and Technology·ends Jan 8, 2028
vol cum
$21.4k
vol 24h
$1.9k
outcomes
5
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
92¢
· 0.0pp
24h change
vol cum
$1.1k
vol 24h
$0
spread
0.08
ends
Jan 8, 2028

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.

timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
Before 2028 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history

similar markets

suggested by pdata